ViewRay (VRAY) Stock Price, News & Analysis

Company Overview

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.03 to $0.65
• 52-Week Range: N/A
• Volume: 108.50 million shs
• Average Volume: 7.51 million shs
• Market Capitalization: $4.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VRAY Stock Analysis - Frequently Asked Questions

How were ViewRay's earnings last quarter?

ViewRay, Inc. (NASDAQ:VRAY) announced its earnings results on Monday, February, 27th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.01. The firm's revenue for the quarter was up 70.1% on a year-over-year basis.

Does ViewRay have any subsidiaries?

The following companies are subsidiaries of ViewRay: Vesuvius Acquisition Corp., ViewRay GmbH, and ViewRay Technologies Inc..

When did ViewRay IPO?

ViewRay (VRAY) raised $52 million in an initial public offering on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

What other stocks do shareholders of ViewRay own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ViewRay investors own include Alibaba Group (BABA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), NVIDIA (NVDA), Bristol Myers Squibb (BMY) and Amarin (AMRN).

Company Calendar

• Last Earnings: 2/27/2023
• Today: 7/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: N/A
• Current Symbol: NASDAQ:VRAY
• CIK: 1597313
• Web: www.viewray.com
• Phone: (440) 703-3210
• Fax: 800-417-3459
• Employees: 295
• Year Founded: 2004

Profitability

• EPS (Trailing Twelve Months): ($0.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$107.33 million
• Net Margins: -104.30%
• Pretax Margin: -104.30%
• Return on Equity: -120.48%
• Return on Assets: -42.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.16
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $105.86 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 183,402,000
• Free Float: 178,817,000
• Market Cap: $4.59 million
• Optionable: Optionable
• Beta: 0.81